Tunedra Advisory Inc. – Trademark Portfolio

Entity Type: 03

Tunedra Advisory Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include TUNEDRA. The owner is based in Calgary, AB.

320, 4620 Bow Trail SW

Calgary, AB T3C3P4 , CA

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Tunedra Advisory Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (4 filings)

Scientific and technological services; industrial analysis and research services

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Tunedra Advisory Inc. have?

Tunedra Advisory Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending, 1 abandoned.

What trademark classes does Tunedra Advisory Inc. file in?

Tunedra Advisory Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Tunedra Advisory Inc.'s most well-known trademarks?

Tunedra Advisory Inc.'s registered trademark portfolio includes well-known marks such as TUNEDRA. These are among 1 currently registered trademark in the portfolio.

What is Tunedra Advisory Inc.'s trademark registration success rate?

Tunedra Advisory Inc. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.